The motion sickness treatment market has evolved steadily over the years driven by expanding scope of pharmacologic therapy. Growing array of medications used in pharmacotherapy to alleviate the symptoms of motion sickness has underlined the lucrativeness quotient for both over-the-counter (OTC) drug makers and prescription drug producers. Particularly, the conspicuous presence of OTC drug manufacturers in developed as well as emerging markets has resulted in a highly fragmented landscape. This has changed the dynamic of competition among the ecosystem of OTC and prescription drug makers in the motion sickness treatment market, notes Transparency Market Research (TMR).


Request a PDF Brochure


Over the past few years, clinicians and the healthcare industries have gained better understanding of the pathophysiology of motion sickness, thereby helping share the varied contours of the motion sickness treatment market. A growing body of clinical studies that evaluate recent drug interventions on the underlying symptoms have been instrumental in broadening the scope of treatments, world over. A range of drug therapies have hit the motion sickness treatment market; however, the adverse side effects are crucial for the medical and patient communities.


The motion sickness treatment market stood at US$ 670.0 Mn in 2017 and is projected to clock a CAGR of more than 3.0% during 2018 - 2026 and touch valuation of US$ 900.0 Mn by the end of 2026.


Request for Analysis of COVID19 Impact on Motion Sickness Treatment Market -


New Generation of Drugs Aim at Reducing Side-Effects


A fast emerging category is anticholinergics, particularly scopolamine, in the motion sickness treatment market. The uptake of anticholinergics in the form of transdermal scopolamine patches has been gathering traction in the market. The anticholinergics segment is expected to hold at least half of the share of the global market during the assessment period. Of note, research and development activities pertaining to the commercialization of intranasal scopolamine are likely to change the future course of the market substantially.


On the other hand, second-generation antihistamines are gathering steam as OTC drug for alleviating or substantially ameliorating the symptoms of motion sickness such as vertigo, nausea, and vomiting. They are being considered clinically better than first-generation ones due to their ability to work via peripheral versus central receptors. However, an assortment of first generation antihistamines are available over the counter and a few have been approved by the FDA for indications in children and adults.


Still, pediatric remains a challenging category for drug manufacturers tapping into the prevailing opportunities in the market. Further, a range of components with possible antihistaminergic effect have been intensively studied, expanding the avenues for growth of the motion sickness treatment market.


Request a Sample of Motion Sickness Treatment Market:


Understanding Use of Symptom Inducing Tech to Drive Future Research in Emerging Markets


Asia Pacific among all regions is emerging as a market with immense potential. The regional market is anticipated to gain shares substantially with the strides the global motion sickness treatment market in the next five years span. Growing penetration of prescription motion sickness drugs among a fast growing numbers of travelers has been fueling its growth. Developed markets, particularly North America, have prospered on the back of large uptake of high-cost prescription drugs. On the other hand, the advent of generic transdermal scopolamine patches will shape the revenue generation of various key regions in the motion sickness treatment market.


Enquiry before Buying Motion Sickness Treatment Market Report -


Rapidly rising use of information technology and virtual reality representations and modern simulation systems that induce motion sickness have considerably shaped our understanding of the etiology of the disease. Tellingly, this will help researchers test new drug intervention approaches. A case in point is neuropharmacological investigations gathering steam among the research community.


The study presented here is based on a report by Transparency Market Research (TMR) titled “Motion Sickness Treatment Market (Treatment Type - Anticholinergic, Antihistamines; Route of Administration - Oral, Transdermal; Distribution Channel - Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026”


More Trending Reports by Transparency Market Research:


Telemedicine Market Telemedicine has evolved gradually with the rise of the Internet age. The ubiquity of smart devices that feature high-quality video transmission has opened up the possibilities of delivering remote healthcare to patients at their convenient locations. Thus, telemedicine is emerging as an alternative for in-person visits for primary as well as specialty care.


Life Sciences BPO Market In the life sciences BPO market, blockchain and serialization technologies are facing the challenges of counterfeit pharmaceuticals. In addition to providing a clearer and better perspective of clinical findings, virtual trials and data management are speeding up the decision making process. Investments in personalized medications and specialist therapies are gaining popularity.


Unfractionated Heparin Market Due to its numerous benefits, unfractionated heparin is gaining popularity. It is generally recognized due to its reversibility (protamine), short half-life, immediate beginning of action, and simple laboratory monitoring. Moreover, it is cost-effective. Unfractionated heparin is also used in the treatment of VTE, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). 


About Us


Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.


Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.


TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.


Contact Us


Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
[email protected]